EHRA Premium Access

Right anterior ganglionated plexus ablation for the treatment of vagally-mediated atrial fibrillation.

Presentation

About the speaker

Associate Professor Piotr Futyma

Medical College, University of Rzeszow and St. Joseph's Heart Rhythm Center, Rzeszow (Poland)
5 presentations
0 follower

7 more presentations in this session

Comparison between oral procainamide and mexiletine for the treatment of recurrent and refractory ventricular tachyarrhythmias.

Speaker: Doctor M. Toniolo (Udine, IT)

Thumbnail

Is it possible to predict mortality and recurrence of VT afterablation? PAINESD risk score applicability vs new predictors

Speaker: Doctor J. Brito (Lisbon, PT)

Thumbnail

Effectiveness and safety of bipolar ablation of heart arrhythmia. A systematic review with meta-analysis.

Speaker: Doctor M. Farkowski (Warsaw, PL)

Thumbnail

Quantifying the variability of bipolar voltage amplitude with sensing angle in residual conduction isthmuses in atrial scar

Speaker: Doctor M. Martinez Cossiani (Madrid, ES)

Thumbnail

Validation of the peak frequency of bipolar electrograms for detection of residual conduction in atrial scar tissue

Speaker: Doctor M. Martinez Cossiani (Madrid, ES)

Thumbnail

Access the full session

Moderated ePosters - Variety on how to improve treatment of arrhythmias

Speakers: Associate Professor P. Futyma, Doctor M. Toniolo, Doctor J. Brito, Doctor M. Farkowski, Doctor M. Martinez Cossiani...
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Early local impedance drop during pulmonary vein isolation using a novel contact force sensing catheter is associated with acute lesion efficacy

4 April 2022

EHRA Premium Access

Novel cryo-balloon technology for a successful pulmonary vein isolation: acute outcome and follow-up from a large multicenter Italian clinical setting

4 April 2022

EHRA Premium Access

Selective epicardial pulsed field ablation of atrial ganglionated plexi causes anti-arrhythmic prolongation of refractoriness: demonstration of feasibility in cardiac surgery patients

3 April 2022

This platform is supported by

logo Novo Nordisk